Reducing unnecessary cervical cancer screenings
De-Implementation of Low-Value Cervical Cancer Screening
This study is looking at ways to help doctors and patients avoid unnecessary cervical cancer screenings that can cause stress and lead to extra treatments, so they can focus on what’s really needed for better health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10899501 on NIH RePORTER |
What this research studies
This research investigates how to effectively reduce the overuse of cervical cancer screenings, which can lead to unnecessary treatments and psychological stress for patients. It will test different strategies aimed at both patients and healthcare providers to decrease the frequency of screenings that are not aligned with current guidelines. The study will involve a randomized controlled trial with approximately 200 clinicians and 2,400 patients in primary care and gynecology clinics, comparing these strategies to standard care. By understanding the factors that contribute to successful de-implementation, the research aims to improve patient care and reduce the harms associated with overscreening.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are currently undergoing cervical cancer screening and may be affected by overscreening practices.
Not a fit: Patients who are not undergoing cervical cancer screening or those who are already receiving appropriate screening based on current guidelines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more appropriate cervical cancer screening practices, reducing unnecessary treatments and improving patient well-being.
How similar studies have performed: Other research has shown success in implementing strategies to improve screening practices, but this specific focus on de-implementation of low-value screenings is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rendle, Katharine a. — University of Pennsylvania
- Study coordinator: Rendle, Katharine a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.